|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.47 USD | -0.31% |
|
-.--% | -.--% |
GENEVA (Reuters) - The GAVI vaccine alliance is in talks with Chinese drugmaker Sinovac Biotch to expand the COVAX dose-sharing portfolio available to poor countries following the World Health Organization's approval of its COVID-19 vaccine on Tuesday, a GAVI spokesperson said.
"Gavi, on behalf of the COVAX Facility, is in dialogue with several manufacturers, including Sinovac, to expand and diversify the portfolio further and secure access to additional doses for Facility participants," she said on Wednesday.
(Reporting by Stephanie Nebehay; editing by Andrew Heavens)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 642M | |
| -2.10% | 89.08B | |
| +2.76% | 40.9B | |
| -12.92% | 32.25B | |
| +54.69% | 25.14B | |
| -16.51% | 15.39B | |
| -8.27% | 11.91B | |
| -42.60% | 11.89B | |
| -12.82% | 11.64B | |
| +7.34% | 9.03B |
SINOVAC BIOTECH LTD. 